Clinical trial NCT03950024: Improvement of Knowledge About the Arthrogenic Muscle Inhibition in the Aftermath of Knee Trauma.
Official title: Contribution of Functional Brain MRI to the Understanding of Arthrogenic Muscle Inhibition (AMI) in the Aftermath of Knee Trauma.
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Anterior Cruciate Ligament Rupture
Keywords: arthrogenic muscle inhibition
anterior cruciate ligament
functional brain MRI
Central nervous system
Knee trauma
Lead sponsor: University Hospital, Toulouse
Sponsor class: OTHER
First posted: 2019-05-14
Enrollment: 42
Sex: MALE
Minimum age (years): 20
Maximum age (years): 30
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: NON_RANDOMIZED
Intervention model: PARALLEL
Intervention model description: prospective, monocentric, interventional, comparative, controlled, non-randomized study
Primary purpose: DIAGNOSTIC

Brief summary: Arthrogenic Muscle Inhibition (AMI) is one of the classic complications occurring in the aftermath of knee trauma; AMI is grossly defined as a lack of extension due to quadriceps inhibition and hamstring contracture. However, its origins remains unknown with a strong suspicion for a central brain origin. It could be the missing link explaining this lack of extension following an anterior cruciate ligament (ACL) rupture. The primary hypothesis of this study is that a difference in activation of motor brain areas exists in patients with an ACL rupture, between those with AMI or without. The second hypothesis is that this difference could be seen on brain functional MRI.

Detailed description: AMI leads to quadriceps atrophy, persistent knee pain, dynamic instability, and a higher rate of osteoarthritis. A recent literature review suggests that the AMI phenomenon is multifactorial, but not widely known and poorly understood. Known mechanisms include impaired motor function at rest, impaired transmission of information from joint sensory receptors, impaired excitability of the spinal reflex and impaired cortical activity. Several studies have suggested a link between ACL rupture and central nervous system reorganization. Among the neurophysiological investigations explored are the evoked somesthesic potentials, electroencephalography, and transcranial magnetic stimulation (TMS). However, these mechanisms alone do not explain the phenomenon in its entirety, suggesting that there are other mechanisms. Furthermore, no study has used functional brain MRI to assess the existence of similar changes in AMI.

This study plans to compare two groups of patients with an ACL rupture: a group with AMI, and a group without AMI. Both groups will undergo a functional brain MRI in order to analyse any modification of the sensory-motor network connectivity that could occur.

Eligibility criteria: Inclusion Criteria:

* male patient, right-handed,
* with a severe right knee sprain in the event of ACL rupture,
* occurrence of trauma within 4 weeks prior to inclusion,
* with a score of ≥ 8/10 on the Edinburgh Manual Laterality Questionnaire, -affiliated or benefiting from public health services.

Exclusion Criteria:

* person presenting any of these conditions : professional player / athlete, -contraindication to the MRI examination (claustrophobic patient, patient with a metallic element),
* patient already operated on with ligament damage to the knee other than ACL,
* patient with iterative ACL rupture,
* patient who has undergone contralateral ligament reconstruction,
* patient with multi-ligamentary knee injury,
* patient refusing to be informed of any abnormality detected on brain MRI, -protected patient (adults under guardianship or other legal protection, deprived of their liberty by judicial or administrative decision).

Primary outcomes:
measure: Matrix of correlation coefficients
timeFrame: Day 0
Secondary outcomes:
measure: Activation map of the motor representations of knee movement
timeFrame: Day 0
Other outcomes:
Locations:
city: Toulouse
country: France
facility: Pierre Paul Riquet Hospital
state: Occitanie
Study officials:
affiliation: University Hospital, Toulouse
name: Etienne CAVAIGNAC, MD
role: PRINCIPAL_INVESTIGATOR
References: